Steroids inhalation therapy in chronic eosinophilic pneumonia

Not Applicable

• Conditions: Eosinophilic pneumonia

• Registration Number: JPRN-UMIN000030830
• Lead Sponsor: Murayama Pediatrics

Brief Summary

Eosinophils were increased in both the BALF (65 %) and peripheral blood (33 %). HLADR expression was increased on CD4-positive T-lymphocytes in the BALF (62.8 %) compared to that on those in the peripheral blood (6.4 %). CD25 expression on CD4-positive T-lymphocytes was also increased (25.5 %) in the BALF compared to that on those in the peripheral blood (15.5 %).

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2004-07-31
• Study Start: 2018-01-16
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: Female
• Target Recruitment: 1

Inclusion Criteria

Not provided

Exclusion Criteria

Nothing

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
CD25 expression on CD4-positive T-lymphocytes was also increased (25.5 %) in the BALF compared to that on those in the peripheral blood (15.5 %).

Secondary Outcome Measures

Name	Time	Method
We tried many ICSs on remmission and acute phase but obtained enough effect in eosinophilic pneumonia.